α-Methylacyl-CoA Racemase: Expression Levels of this Novel Cancer Biomarker Depend on Tumor Differentiation
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (3) , 841-848
- https://doi.org/10.1016/s0002-9440(10)64244-7
Abstract
No abstract availableKeywords
Funding Information
- University of Michigan (379206)
- National Cancer Institute (379206)
This publication has 32 references indexed in Scilit:
- MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2001
- Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the ColonThe American Journal of Pathology, 2001
- P504SThe American Journal of Surgical Pathology, 2001
- Relational Database Structure to Manage High-Density Tissue Microarray Data and Images for Pathology Studies Focusing on Clinical Outcome: The Prostate Specialized Program of Research Excellence ModelThe American Journal of Pathology, 2001
- Fat reduction to prevent prostate cancer: waiting for more evidence?Current Opinion in Urology, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Diet and CancerThe Oncologist, 2000
- In Mouse α-Methylacyl-CoA Racemase, the Same Gene Product Is Simultaneously Located in Mitochondria and PeroxisomesPublished by Elsevier ,2000
- Purification and Characterization of an alpha-Methylacyl-CoA Racemase from Human LiverEuropean Journal of Biochemistry, 1995